JPH0130803B2 - - Google Patents
Info
- Publication number
- JPH0130803B2 JPH0130803B2 JP20667885A JP20667885A JPH0130803B2 JP H0130803 B2 JPH0130803 B2 JP H0130803B2 JP 20667885 A JP20667885 A JP 20667885A JP 20667885 A JP20667885 A JP 20667885A JP H0130803 B2 JPH0130803 B2 JP H0130803B2
- Authority
- JP
- Japan
- Prior art keywords
- dextranase
- hydroxyapatite
- toothpaste
- immobilized
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108010001682 Dextranase Proteins 0.000 claims description 34
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 34
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 34
- 239000000203 mixture Substances 0.000 claims description 18
- 239000000551 dentifrice Substances 0.000 claims description 9
- 229940034610 toothpaste Drugs 0.000 description 19
- 239000000606 toothpaste Substances 0.000 description 19
- 238000000034 method Methods 0.000 description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 7
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- 235000012239 silicon dioxide Nutrition 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 5
- 229910014497 Ca10(PO4)6(OH)2 Inorganic materials 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 108010014251 Muramidase Proteins 0.000 description 4
- 102000016943 Muramidase Human genes 0.000 description 4
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
- 208000002925 dental caries Diseases 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 229960000274 lysozyme Drugs 0.000 description 4
- 239000004325 lysozyme Substances 0.000 description 4
- 235000010335 lysozyme Nutrition 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- 229940043256 calcium pyrophosphate Drugs 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 3
- 239000008057 potassium phosphate buffer Substances 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000011632 Caseins Human genes 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 2
- 102000018832 Cytochromes Human genes 0.000 description 2
- 108010052832 Cytochromes Proteins 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 230000001588 bifunctional effect Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940095688 toothpaste product Drugs 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 239000004604 Blowing Agent Substances 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000001027 hydrothermal synthesis Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Description
(産業上の利用分野)
本願発明は虫歯予防用歯磨組成物、詳しくはデ
キストラナーゼを固定したハイドロキシアパタイ
トを含有する歯磨組成物に関する。
(従来の技術)
デキストラナーゼはそのデキストラン分解能に
より、歯垢溶解作用を有するため、これを配合し
た歯磨組成物は良好な虫歯予防効果を有すること
が知られている(特許第782154号公報)。しかし
ながら、デキストラナーゼは比較的安定性に乏し
く、これを配合した歯磨製品は経時的にデキスト
ラナーゼが分解失活し易く、これを安定に保つた
め、適当な安定化剤の併用が必要であるとされ、
種々の工夫が提案されている。例えば発泡剤とし
て歯磨組成物に使用されているアニオン活性剤
は、デキストラナーゼの分解を促進する。これを
防止するため、テルペン系炭化水素、脂肪族アル
コール系香料を併用する試み(特許第9242229号
公報)、カルボン、l−メントールを特定比率で
併用する方法(特開昭56−110609号公報)、或は
酸化アルミニウムを研磨剤として使用する方法
(特開昭56−63915号公報)などが提案されてい
る。一方歯磨製品は口腔内で使用するので安全
で、優れた使用感が要求される。従つてデキスト
ラナーゼの安定性、口腔内での使用感の優秀性及
び安全性がデキストラナーゼ添加歯磨製品に要求
されているデキストラナーゼの安全性と使用感と
を両立させることが相当な困難を残していると云
える。
(発明が解決しようとする問題点)
本願発明は従来のデキストラナーゼ含有歯磨製
品にみられる添加物使用による安定性と使用感と
を両立させる上で生じる問題点を解消し、デキス
トラナーゼ安定化剤の添加を必要としない優れた
虫歯予防効果を有するデキストラナーゼ配合歯磨
組成物を提供することにある。
(問題点を解決するための手段)
歯磨組成物の調製に使用する研磨剤として硬度
が歯牙がホーロー質のそれに近いハイドロキシア
パタイトが、歯牙の清掃、保存の上から好適であ
ることが知られている(特開昭56−73014号明細
書)。そこで、口腔衛生組成物として従来からそ
の効果の認められているデキストラナーゼを、ハ
イドロキシアパタイトに安定に固定化することが
可能であれば、そのようにして調製したハイドロ
キシアパタイトを配合成分として使用することに
よつて、目的にそつた歯磨製品が得られるとの考
えにもとずき種々検討した結果、本願発明を完成
することができた。最近、酵素の固定化について
多くの知見がえられている。例えば酵素の特性と
して蛋白質に吸着されやすいこと、酵素と蛋白質
との間で二官能性物質により架橋結合が生じ酵素
は不溶化し安定化することなどが知られている。
一方、ハイドロキシアパタイトは微粒子化する
ことにより、強力な吸着性を発揮する。我々はこ
の事項に着目して、種々検討の結果デキストラナ
ーゼを安定固定化したハイドロキシアパタイトの
調製法を先に特許出願した。即ち、低温の水媒体
中において、リゾチーム、カゼイン、アルブミン
又はチトクロームCなどからえらばれた蛋白質、
デキストラナーゼ、及びハイドロキシアパタイト
を混合撹拌しながら、これにグルタルアルデヒド
のような2官能性物質を徐々に添加することによ
りデキストラナーゼを固定化したハイドロキシア
パタイトをえる。使用するハイドロキシアパタイ
トは通常歯磨組成物に使用されるものであり、デ
キストラナーゼと蛋白質とはほゞ等量使用され、
総蛋白質に対し10〜100倍のハイドロキシアパタ
イトを使用する。使用する水媒体のPHは5.6〜9.0
の間であり、添加グルタルアルデヒド量は多量に
なると酵素が失活するので出来るだけ少量である
ことが好ましい。この方法によるとデキストラナ
ーゼを固定化したハイドロキシアパタイト粉末が
容易に得られるので、これを研磨剤として使用
し、通常の歯磨組成物の配合処方に準拠して製品
を調製し、優れた虫歯予防効果をもつ歯磨製品を
えることができる。
(作 用)
先に特許出願した方法で調製したデキストラナ
ーゼ固定化ハイドロキシアパタイトを配合成分に
使用した歯磨製品は、従来のデキストラナーゼに
安定化剤を配合してなる歯磨製品とことなり、デ
キストラナーゼは研磨剤ハイドロキシアパタイト
に固定化されているので、安定性にすぐれ、製品
貯蔵中のデキストラナーゼの分解、失活が防止で
きる。他の配合成分、例えばアニオン系活性剤の
発泡剤の存在においても安定である。さらに又、
製品の使用時口腔内において、イオン、PH、など
の諸要因によるデキストラナーゼの分解は阻止さ
れると同時に、デキストラナーゼの効果は比較的
長期にわたつて継続する。すなわち、口中におい
て、ハイドロキシアパタイト粒子の末端、及び/
又はデキストラナーゼの末端が歯牙表面エナメル
層に吸着して、比較的長期にわたつてデキストラ
ナーゼが口腔内に滞留し、歯垢の分解作用が永続
するものと推定される。
デキストラナーゼ固定化ハイドロキシアパタイ
トは後述の方法によつて調製できる。本願発明の
歯磨組成物の調製には特別の手法を必要としな
い。すなわち、従来の歯磨組成物の配合におい
て、少くとも使用研磨剤の全部又は一部を、後記
方法にしたがつて調製したデキストラナーゼ固定
化ハイドロキシアパタイトで置換すればよい。
(実施例)
以下例により本願発明を説明するが、これらの
例は、組成物を重量部で示したものである。
例 1
練歯磨
デキストラナーゼ固定ハイドロキシアパタイト
13.2
リン酸カルシウム 25.0
CMCナトリウム塩 0.3
カラギーナン 1.2
グリセリン 10.0
ソルビツト 15.0
ラウリル硫酸ナトリウム 2.0
香 料 1.2
サツカリンナトリウム 0.1
二酸化ケイ素 2.0
水 30.0
例 2
練歯磨
デキストラナーゼ固定ハイドロキシアパタイト
7.2
リン酸カルシウム 10.0
ピロリン酸カルシウム 20.0
CMCナトリウム塩 1.0
アルギン酸ナトリウム塩 0.1
グリセリン 10.0
ソルビツト 10.0
ラウリル硫酸ナトリウム 1.5
ラウロイルザルコシナトリウム 0.5
香 料 0.5
サツカリンナトリウム 0.1
二酸化ケイ素 2.5
リン酸ナトリウム 1.0
水 35.0
例 3
練歯磨
デキストラナーゼ固定ハイドロキシアパタイト
20.0
ピロリン酸カルシウム 10.0
CMCナトリウム塩 0.5
カラギーナン 0.6
グリセリン 20.0
ソルビツト 10.0
ラウリル硫酸ナトリウム 2.0
香 料 1.0
サツカリンナトリウム 0.1
二酸化ケイ素 2.0
KCl 2.0
MgCl2 0.3
リン酸ナトリウム 0.5
水 30.0
例 4
練歯磨
デキストラナーゼ固定ハイドロキシアパタイト
35.0
CMCナトリウム塩 1.0
カラギーナン 0.3
グリセリン 35.0
ラウリル硫酸ナトリウム 2.0
香 料 1.0
サツカリンナトリウム 0.1
二酸化ケイ素 2.5
NaCl 2.0
MgCl2 0.1
KCl 1.0
水 20.0
例 5
粉歯磨
デキストラナーゼ固定ハイドロキシアパタイト
90.8
ラウリル硫酸ナトリウム 2.0
香 料 1.5
サツカリンナトリウム 0.2
NaCl 5.0
MgCl2 0.5
例 6
粉歯磨
デキストラナーゼ固定ハイドロキシアパタイト
38.0
ピロリン酸カルシウム 50.0
二酸化ケイ素 5.0
ラウリル硫酸ナトリウム 2.0
香 料 2.0
サツカリンナトリウム 0.3
NaCl 1.8
MgCl2 0.2
リン酸カリウム 0.7
例 7
潤性歯磨
デキストラナーゼ固定ハイドロキシアパタイト
63.0
リン酸カルシウム 10.0
ソルビツト 10.0
ラウリル硫酸ナトリウム 2.0
香 料 1.5
NaCl 3.3
MgCl2 0.08
サツカリン 0.12
水 10.0
実施例に使用されたデキストラナーゼ固定化ハ
イドロキシアパタイトは次のように調製した。
デキストラナーゼ固定化ハイドロキシアパタイト
の調製。各例で使用したハイドロキシアパタイト
は、以下に記する方法により調製した。即ち、例
1のハイドロキシアパタイトは、乾式合成法、
6CaHPO4+4CaCO3→Ca10(PO4)6(OH)2、例2
及び例3のそれは、水熱合成法、CaHPO4・
2H2O→Ca10(PO4)6(OH)2、例4及び例5のそれ
は、湿式合成法、CaCl2+H3PO4→Ca10(PO4)6
(OH)2、例6及び例7のそれは、湿式合成法、
Ca(OH)2+H3PO4→Ca10(PO4)6(OH)2なる反応
により合成し、乾燥粉砕して固定化のためのハイ
ドロキシアパタイトとして使用した。
デキストラナーゼ50mg、リゾチーム50mg、ハイ
ドロキシアパタイト粉末5gを混合し、0.05モル
濃度PH6.8リン酸カリ緩衝溶液500mlを添加し、撹
拌下に4℃で0.2%グルタルアルデヒド水溶液
500μlを徐々に滴下し、終つて4℃で5時間撹拌
を続行する。反応物を採取し、100mlの上記緩衝
溶液を用いて3回洗浄して未反応を除去した後残
留物を凍結乾燥して5.06gをえた。この約1gを
精秤し、1モル濃度PH6.8リン酸カリ緩衝溶液20
mlを加えて3時間撹拌し遠心分離し、沈殿物を洗
浄し液と合してローリー法により蛋白質を測定
し、乾燥ハイドロキシアパタイトg当り10.9mgの
蛋白質を吸着していることを認めた。この蛋白質
のデキストラナーゼ活性を測定の結果2時間でデ
キストラン0.513g/蛋白質gを分解することを
確めた。えられたデキストラナーゼ固定化ハイド
ロキシアパタイトのデキストラナーゼ活性は生成
直後より時間と共に活性を増加し、ある期間で最
高の活性を示し以後徐々に活性を低下する。リゾ
チームの代りにアルブミン、カゼイン、チトクロ
ムC使用してもリゾチームと同様デキストラナー
ゼ固定化ハイドロキシアパタイトをえることがで
きる。
デキストラナーゼ活性の経時変化
例4におけるデキストラナーゼ固定化ハイドロ
キシアパタイト35gの代りに、ハイドロキシアパ
タイト35g、デキストラナーゼ350mgを含み他の
試薬を等量とし水で100gに調製した練歯磨を作
成し、対照とした。各歯磨きを2g精秤し、PH
7.0の0.05モルリン酸カリ緩衝溶液にデキストラ
ン1%を溶かした溶液10mlを加え35℃、2時間撹
拌後、遠心分離し、残査を同緩衝溶液で洗浄後、
遠心分離液と合せグルコースオキシダーゼにより
生成したグルコース量を経時的に測定して以下の
結果をえた。
(Industrial Application Field) The present invention relates to a dentifrice composition for preventing dental caries, and more particularly to a dentifrice composition containing hydroxyapatite with fixed dextranase. (Prior art) Dextranase has a plaque-dissolving effect due to its ability to decompose dextran, and it is known that toothpaste compositions containing this have a good caries prevention effect (Patent No. 782154). . However, dextranase has relatively poor stability, and dextranase in toothpaste products that contain it tends to decompose and deactivate over time. To keep it stable, it is necessary to use an appropriate stabilizer. It is said that there is
Various ideas have been proposed. Anionic active agents used in dentifrice compositions, for example as foaming agents, promote the degradation of dextranase. To prevent this, attempts have been made to use terpene-based hydrocarbons and aliphatic alcohol flavorings in combination (Patent No. 9242229), and methods to use carvone and l-menthol together in a specific ratio (Japanese Patent Laid-Open No. 110609/1982) , or a method using aluminum oxide as an abrasive (Japanese Unexamined Patent Publication No. 56-63915) has been proposed. On the other hand, since toothpaste products are used in the oral cavity, they are required to be safe and have an excellent usability. Therefore, it is important to achieve both the stability of dextranase, the excellent feeling of use in the oral cavity, and the safety of dextranase, which are required for dentifrice products containing dextranase. It can be said that difficulties remain. (Problems to be Solved by the Invention) The present invention solves the problems that arise in achieving both stability and usability due to the use of additives in conventional dextranase-containing dentifrice products, and stabilizes dextranase. An object of the present invention is to provide a dextranase-containing dentifrice composition that does not require the addition of a curing agent and has an excellent caries-preventing effect. (Means for solving the problem) It is known that hydroxyapatite, which has a hardness close to that of enamel teeth, is suitable as an abrasive used in the preparation of toothpaste compositions from the viewpoint of cleaning and preserving teeth. (Japanese Unexamined Patent Publication No. 56-73014). Therefore, if it is possible to stably immobilize dextranase, which has been recognized as effective in oral hygiene compositions, on hydroxyapatite, then the hydroxyapatite prepared in this way can be used as a compounding ingredient. As a result of various studies based on the idea that by doing so, a toothpaste product that meets the purpose can be obtained, the present invention was completed. Recently, much knowledge has been obtained regarding enzyme immobilization. For example, it is known that enzymes have characteristics such that they are easily adsorbed by proteins, and that cross-linking occurs between enzymes and proteins due to bifunctional substances, making the enzyme insolubilized and stabilized. On the other hand, when hydroxyapatite is made into fine particles, it exhibits strong adsorption properties. Focusing on this matter, we have previously filed a patent application for a method for preparing hydroxyapatite in which dextranase is stably immobilized as a result of various studies. That is, in a low-temperature aqueous medium, proteins selected from lysozyme, casein, albumin, cytochrome C, etc.
Hydroxyapatite with immobilized dextranase is obtained by gradually adding a bifunctional substance such as glutaraldehyde to dextranase and hydroxyapatite while stirring. The hydroxyapatite used is normally used in toothpaste compositions, and the dextranase and protein are used in approximately equal amounts.
Use 10 to 100 times more hydroxyapatite than total protein. The pH of the water medium used is 5.6 to 9.0
The amount of glutaraldehyde added is preferably as small as possible since the enzyme will be inactivated if the amount is too large. According to this method, hydroxyapatite powder with immobilized dextranase can be easily obtained, and this can be used as an abrasive and a product prepared according to the formulation of ordinary toothpaste compositions, which can be used as an excellent preventive agent for tooth decay. You can get effective toothpaste products. (Function) A toothpaste product that uses dextranase-immobilized hydroxyapatite prepared using the method for which a patent application was previously applied is different from conventional toothpaste products that contain dextranase and a stabilizer. Since dextranase is immobilized on the abrasive hydroxyapatite, it has excellent stability and can prevent decomposition and deactivation of dextranase during product storage. It is also stable in the presence of other formulation ingredients, such as blowing agents such as anionic active agents. Furthermore,
When the product is used in the oral cavity, the decomposition of dextranase due to various factors such as ions and pH is prevented, and at the same time, the effects of dextranase continue for a relatively long period of time. That is, in the mouth, the ends of the hydroxyapatite particles and/or
Alternatively, it is presumed that the terminal end of dextranase is adsorbed to the tooth surface enamel layer, and the dextranase stays in the oral cavity for a relatively long period of time, thereby making the plaque decomposition effect permanent. Dextranase-immobilized hydroxyapatite can be prepared by the method described below. No special technique is required to prepare the dentifrice composition of the present invention. That is, in the formulation of conventional dentifrice compositions, at least all or part of the abrasive used may be replaced with dextranase-immobilized hydroxyapatite prepared according to the method described below. (Examples) The present invention will be explained with reference to the following examples, in which the compositions are expressed in parts by weight. Example 1 Toothpaste dextranase fixed hydroxyapatite
13.2 Calcium phosphate 25.0 CMC sodium salt 0.3 Carrageenan 1.2 Glycerin 10.0 Sorbit 15.0 Sodium lauryl sulfate 2.0 Flavoring 1.2 Sodium saccharin 0.1 Silicon dioxide 2.0 Water 30.0 Example 2 Toothpaste dextranase-fixed hydroxyapatite
7.2 Calcium phosphate 10.0 Calcium pyrophosphate 20.0 CMC sodium salt 1.0 Sodium alginate 0.1 Glycerin 10.0 Sorbit 10.0 Sodium lauryl sulfate 1.5 Sodium lauroyl sarcosinate 0.5 Flavor 0.5 Sodium saccharin 0.1 Silicon dioxide 2.5 Sodium phosphate 1.0 Water 35.0 Example 3 toothpaste dextranase fixed hydroxyapatite
20.0 Calcium pyrophosphate 10.0 CMC sodium salt 0.5 Carrageenan 0.6 Glycerin 20.0 Sorbit 10.0 Sodium lauryl sulfate 2.0 Flavoring 1.0 Satucharin sodium 0.1 Silicon dioxide 2.0 KCl 2.0 MgCl 2 0.3 Sodium phosphate 0.5 Water 30.0 Example 4 Toothpaste dextraner Ze-fixed hydroxyapatite
35.0 CMC sodium salt 1.0 Carrageenan 0.3 Glycerin 35.0 Sodium lauryl sulfate 2.0 Flavoring 1.0 Satucalin sodium 0.1 Silicon dioxide 2.5 NaCl 2.0 MgCl 2 0.1 KCl 1.0 Water 20.0 Example 5 Toothpaste dextranase-fixed hydroxyapatite
90.8 Sodium lauryl sulfate 2.0 Flavoring 1.5 Satucharin sodium 0.2 NaCl 5.0 MgCl 2 0.5 Example 6 Toothpaste dextranase-fixed hydroxyapatite
38.0 Calcium pyrophosphate 50.0 Silicon dioxide 5.0 Sodium lauryl sulfate 2.0 Flavoring 2.0 Satucharin sodium 0.3 NaCl 1.8 MgCl 2 0.2 Potassium phosphate 0.7 Example 7 Moisturizing toothpaste dextranase-fixed hydroxyapatite
63.0 Calcium phosphate 10.0 Sorbit 10.0 Sodium lauryl sulfate 2.0 Flavor 1.5 NaCl 3.3 MgCl 2 0.08 Satucalin 0.12 Water 10.0 The dextranase-immobilized hydroxyapatite used in the examples was prepared as follows. Preparation of dextranase-immobilized hydroxyapatite. Hydroxyapatite used in each example was prepared by the method described below. That is, the hydroxyapatite of Example 1 was produced by dry synthesis method,
6CaHPO 4 +4CaCO 3 →Ca 10 (PO 4 ) 6 (OH) 2 , Example 2
and that of Example 3 is a hydrothermal synthesis method, CaHPO4・
2H 2 O→Ca 10 (PO 4 ) 6 (OH) 2 , that of Examples 4 and 5 is a wet synthesis method, CaCl 2 +H 3 PO 4 →Ca 10 (PO 4 ) 6
(OH) 2 , that of Examples 6 and 7, is a wet synthesis method,
It was synthesized by the reaction Ca(OH) 2 +H 3 PO 4 →Ca 10 (PO 4 ) 6 (OH) 2 , dried and ground, and used as hydroxyapatite for immobilization. Mix 50 mg of dextranase, 50 mg of lysozyme, and 5 g of hydroxyapatite powder, add 500 ml of 0.05 molar concentration PH6.8 potassium phosphate buffer solution, and keep stirring at 4°C with 0.2% glutaraldehyde aqueous solution.
500 μl was gradually added dropwise, and stirring was continued for 5 hours at 4°C. The reaction product was collected and washed three times with 100 ml of the above buffer solution to remove unreacted material, and the residue was lyophilized to obtain 5.06 g. Weigh out approximately 1 g of this accurately, add 1 molar concentration PH6.8 potassium phosphate buffer solution 20
ml was added, stirred for 3 hours, centrifuged, the precipitate was washed and combined with the liquid, and protein was measured by the Lowry method, and it was found that 10.9 mg of protein was adsorbed per g of dry hydroxyapatite. As a result of measuring the dextranase activity of this protein, it was confirmed that 0.513 g of dextran/g of protein was degraded in 2 hours. The dextranase activity of the obtained dextranase-immobilized hydroxyapatite increases with time from immediately after production, reaches the highest activity for a certain period of time, and then gradually decreases. Dextranase-immobilized hydroxyapatite can be obtained similarly to lysozyme by using albumin, casein, or cytochrome C instead of lysozyme. Changes over time in dextranase activity Instead of 35 g of dextranase-immobilized hydroxyapatite in Example 4, a toothpaste containing 35 g of hydroxyapatite, 350 mg of dextranase, and other reagents in equal amounts and water to make 100 g was prepared. , served as a control. Weigh 2g of each toothpaste accurately, and check the pH
Add 10 ml of a solution of 1% dextran dissolved in a 0.05 molar potassium phosphate buffer solution of 7.0, stir at 35°C for 2 hours, centrifuge, and wash the residue with the same buffer solution.
The amount of glucose produced by glucose oxidase in combination with the centrifuged solution was measured over time, and the following results were obtained.
【表】
(発明の効果)
デキストラナーゼを固定化したハイドロキシア
パタイトを歯磨きに入れることにより、デキスト
ラナーゼの効力の安定な、配合に特別の配慮を要
しない歯磨きをえることができる。[Table] (Effects of the Invention) By incorporating hydroxyapatite with immobilized dextranase into toothpaste, it is possible to obtain a toothpaste with stable dextranase efficacy and which does not require special consideration in its formulation.
Claims (1)
アパタイトを含有する歯磨組成物。1. A dentifrice composition containing hydroxyapatite with immobilized dextranase.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20667885A JPS6267013A (en) | 1985-09-20 | 1985-09-20 | Dentifrice composition |
| CA 517895 CA1281658C (en) | 1985-09-20 | 1986-09-10 | Dentifrice compositions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20667885A JPS6267013A (en) | 1985-09-20 | 1985-09-20 | Dentifrice composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6267013A JPS6267013A (en) | 1987-03-26 |
| JPH0130803B2 true JPH0130803B2 (en) | 1989-06-22 |
Family
ID=16527299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP20667885A Granted JPS6267013A (en) | 1985-09-20 | 1985-09-20 | Dentifrice composition |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS6267013A (en) |
| CA (1) | CA1281658C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0228563B2 (en) * | 1986-04-22 | 1990-06-25 | Dental Chem Co Ltd | HAMIGAKISOSEIBUTSU |
| JPS6470408A (en) * | 1987-09-10 | 1989-03-15 | Hairu Kk | Dentifrice composition |
| JPH0737374B2 (en) * | 1990-12-27 | 1995-04-26 | 株式会社ハームレスプロダクト | Toothpaste |
-
1985
- 1985-09-20 JP JP20667885A patent/JPS6267013A/en active Granted
-
1986
- 1986-09-10 CA CA 517895 patent/CA1281658C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA1281658C (en) | 1991-03-19 |
| JPS6267013A (en) | 1987-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4837008A (en) | Periodontal composition and method | |
| US5403578A (en) | Stable tooth and gum dentifrice with microencapsulation and method for making same | |
| JPH0231049B2 (en) | ||
| EP0305365B1 (en) | Periodontal composition and method | |
| CN100435776C (en) | Enzyme-containing dual component toothpaste composition | |
| US5788951A (en) | Dual component dentifrice composition for fluoridating teeth containing compatible silica abrasive | |
| JPH03169810A (en) | Mouth application composition containing monoperoxy acids | |
| JPH0130803B2 (en) | ||
| US3981989A (en) | Oral preparation | |
| EP1236461A1 (en) | Toothpaste compositions | |
| JP3336688B2 (en) | Oral composition | |
| JPH0925221A (en) | Tongue coating remover | |
| JPH11130643A (en) | Oral composition | |
| JPH03128313A (en) | Dentifrice composition | |
| AU599387B2 (en) | Dentifrice compositions comprising hydroxyapatite in which glucanase is immobilized therein | |
| JP2005041787A (en) | Dentifrice composition | |
| JPH11130648A (en) | Oral composition | |
| KR910003554B1 (en) | Stable antiplague dentifrice with improved foaming and fluoride stability | |
| JPH07187975A (en) | Oral composition | |
| JPS58225007A (en) | Oral composition | |
| JPH1135438A (en) | Oral composition | |
| JPS643165B2 (en) | ||
| JPH0136802B2 (en) | ||
| JPH09235215A (en) | Oral composition | |
| JP2848679B2 (en) | Oral composition |